Results 31 to 40 of about 896,879 (225)

Early dissemination of OXA-72-producing Acinetobacter baumannii strain in Colombia: a case report

Brazilian Journal of Infectious Diseases, 2014
Nosocomial infections caused by carbapenem-resistant Acinetobacter baumannii isolates have reached epidemic levels in past decades. Currently this microorganism is responsible for outbreaks of difficult eradication and with high mortality rates worldwide.
Sandra Yamile Saavedra, Rodrigo Cayô, Ana Cristina Gales, Aura Lucia Leal, Carlos Humberto Saavedra   +4 more
doaj   +1 more source

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.

Antibiotics, 2021
Treatment of infections caused by Acinetobacter spp., particularly A. baumannii, is a major clinical problem due to its high rates of antibiotic resistance.
Cristina Lasarte-Monterrubio, Juan C. Vázquez-Ucha, Maria Maneiro, Jorge Arca-Suárez, Isaac Alonso, Paula Guijarro-Sánchez, John D. Buynak, Germán Bou, Concepción González-Bello, Alejandro Beceiro   +9 more
doaj   +1 more source

Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates

Frontiers in Cellular and Infection Microbiology, 2022
ObjectivesThe spread of antibiotic resistant bacteria is an important threat for human health. Acinetobacter baumannii bacteria impose such a major issue, as multidrug- to pandrug-resistant strains have been isolated, rendering some infections ...
Anke Breine, Anke Breine, Mégane Van Gysel, Mathias Elsocht, Clémence Whiteway, Clémence Whiteway, Chantal Philippe, Théo Quinet, Théo Quinet, Adam Valcek, Adam Valcek, Johan Wouters, Steven Ballet, Charles Van der Henst, Charles Van der Henst   +14 more
doaj   +1 more source

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment [PDF]

Clinical Microbiology and Infection, 2019
Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients, causing pneumonia and bloodstream infections with high mortality rates. Difficulties in treating CRAB infections stem from a formidable resistance profile that leaves available only a few
Piperaki, E.-T., Tzouvelekis, L.S., Miriagou, V., Daikos, G.L.   +3 more
openaire   +3 more sources

Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell

Frontiers in Immunology, 2017
Acinetobacter baumannii, an opportunistic ESKAPE pathogen, causes respiratory and urinary tract infections. Its prevalence increases gradually in the clinical setup.
Vishvanath Tiwari, Monalisa Tiwari, Vandana Solanki   +2 more
doaj   +1 more source

Antibacterial activity of silver nanoparticles against carbapenem-resistant Acinetobacter baumannii clinical isolates

, 2022
: Carbapenem-resistant Acinetobacter baumannii (CRAB) produce resistance to various classes of ...

core   +1 more source

Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities

Journal of Infection in Developing Countries, 2009
Acinetobacter baumannii is an opportunistic gram-negative pathogen with increasing relevance in a variety of nosocomial infections especially among intensive-care-unit (ICU) patients. Carbapenems have been widely used to treat serious multidrug-resistant
Raffaele Zarrilli, Maria Giannouli, Federica Tomasone, Maria Triassi, Athanassios Tsakris   +4 more
doaj   +1 more source

Case report: Successful treatment of OXA-23 Acinetobacter baumannii neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy

Frontiers in Medicine
Meningitis caused by Acinetobacter species is a rare complication of neurosurgical procedures, although it is associated with high morbidity and mortality.
Jacob W. Snowdin, Nicholas J. Mercuro, Michael P. Madaio, Stephen A. Rawlings   +3 more
doaj   +1 more source

Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species

Microbiology Spectrum, 2022
Carbapenem resistance is increasing among Gram-negative bacteria, including the genus Acinetobacter. This study aimed to characterize, for the first time, the development of carbapenem resistance in clinical isolates of Acinetobacter junii and ...
Cristina Lasarte-Monterrubio, Paula Guijarro-Sánchez, Alba Bellés, Juan Carlos Vázquez-Ucha, Jorge Arca-Suárez, Carlos Fernández-Lozano, German Bou, Alejandro Beceiro   +7 more
doaj   +1 more source

Sulbactam–Durlobactam for Carbapenem-Resistant Acinetobacter baumannii–calcoaceticus Complex

Pathogens
Carbapenem-resistant Acinetobacter baumannii infections pose a significant challenge due to their severity and the poor prognoses they often result in, particularly in cases where there are risk factors present. The United States (US) Centers for Disease
Francesco Nappi
doaj   +1 more source